Managed Healthcare Executive December 7, 2022
Susan Ladika

Cuban’s Cost Plus Drugs business has entered into agreements with Capital Blue Cross and Rightway.

Billionaire Mark Cuban’s Cost Plus Drugs venture, which is aimed at offering low-priced generic drugs, is gradually gaining traction, signing its first agreement with a health insurance company. Capital Blue Cross in Harrisburg, Pennsylvania, announced in October that it was teaming up with Cost Plus Drugs, because the payer “is always looking for ways to control costs for our members and employer groups,” Samir Mistry, Pharm.D., MBA, vice president of pharmacy strategy and services at Capital Blue Cross, said in an email.

Capital Blue Cross approached Cuban’s company to help provide “another option for people to obtain affordable medications,” Mistry said. “We want to increase...

Today's Sponsors

Transcarent
SalesSparx

Today's Sponsor

Health Edge

 
Topics: Insurance, Payer, Pharma, Pharma / Biotech
J&J's pharma group quietly works through global overhaul, with layoffs expected to reach multiple countries
Inflation Reduction Act Could Cut Medicare Drug Spending by 5%, Study Suggests
Amazon’s RxPass Doesn’t Yet Really Compete With Mark Cuban’s Cost Plus Drug Company
2023’s Biggest Pharma Cybersecurity Threats to Watch
Smoothing Medicare Part D Out-Of-Pocket Costs Under The Inflation Reduction Act

Share This Article